Skip Navigation
NCI banner National Cancer Institute U.S. National Institutes of Health National Cancer Institute
Chromosomes
  • Tools
  • Genetic and Physical SNP Maps
  • SNP500Cancer
Cancer Genome Characterization Initiative

Visit the database of genomic characterization data for multiple tumor types.

Association List

[Full Text]
Displaying Investigations 1 to 44 of 44 found
From 8 References


Asmann et al 2011, Nucleic Acids Res
  Adenocarcinoma Breast
BRE/DPYSL5
t(2;2)(p23;p23)

Hu et al 2018, Nucleic Acids Res
  Adenocarcinoma Uterus, corpus
ALK/GALNT14
t(2;2)(p23;p23)
  Transitional cell carcinoma Bladder
BRE/DTNB
t(2;2)(p23;p23)
  Adenocarcinoma Uterus, corpus
BRE/GPN1
t(2;2)(p23;p23)
  Adenocarcinoma Breast
CENPO/NCOA1
t(2;2)(p23;p23)
  Adenocarcinoma Liver
DNMT3A/HADHA
t(2;2)(p23;p23)
  Malignant melanoma Skin
DNMT3A/DTNB
t(2;2)(p23;p23)
  Adenocarcinoma Kidney
DNMT3A/GTF3C2
t(2;2)(p23;p23)
  Adenocarcinoma Breast
DTNB/ASXL2
t(2;2)(p23;p23)
  Adenocarcinoma Breast
FOSL2/BRE
t(2;2)(p23;p23)
  Adenocarcinoma Ovary
KIF3C/ADCY3
t(2;2)(p23;p23)
  Malignant melanoma Skin
NCOA1/ALK
t(2;2)(p23;p23)
  Malignant melanoma Skin
NCOA1/UBXN2A
t(2;2)(p23;p23)
  Squamous cell carcinoma Lung
PPM1G/IFT172
t(2;2)(p23;p23)
  Adenocarcinoma Uterus, corpus
PPP1CB/FOSL2
t(2;2)(p23;p23)

Kalyana-Sundaram et al 2012, Neoplasia
  Adenocarcinoma Breast
FOSL2/BRE
t(2;2)(p23;p23)

Liu et al 2017, Nat Genet
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
ASXL2/PFN4
t(2;2)(p23;p23)
T-Lineage

Velusamy et al 2013, Proc Natl Acad Sci U S A
  Chronic lymphocytic leukemia
YPEL5/PPP1CB
t(2;2)(p23;p23)
B-Lineage
  Chronic lymphocytic leukemia
PPP1CB/YPEL5
t(2;2)(p23;p23)
B-Lineage

Yakirevich et al 2016, Clin Cancer Res
  Adenocarcinoma Large intestine
MAPRE3/ALK
t(2;2)(p23;p23)
  Adenocarcinoma Large intestine
C2ORF44/ALK
t(2;2)(p23;p23)
  Adenocarcinoma Large intestine
CAD/ALK
t(2;2)(p23;p23)

Yoshihara et al 2015, Oncogene
  Adenocarcinoma Prostate
ASXL2/C2orf44
t(2;2)(p23;p23)
  Squamous cell carcinoma Lung
FOSL2/BRE
t(2;2)(p23;p23)
  Adenocarcinoma Ovary
ZNF512/KCNK3
t(2;2)(p23;p23)
  Adenocarcinoma Ovary
PPP1CB/PLB1
t(2;2)(p23;p23)
  Adenocarcinoma Ovary
CLIP4/BRE
t(2;2)(p23;p23)
  Adenocarcinoma Ovary
KIF3C/RBKS
t(2;2)(p23;p23)
  Adenocarcinoma Lung
MRPL33/RBKS
t(2;2)(p23;p23)
  Adenocarcinoma Lung
CAPN13/GALNT14
t(2;2)(p23;p23)
  Astrocytoma, grade I-II Brain
CENPO/UBXN2A
t(2;2)(p23;p23)
  Squamous cell carcinoma Oral cavity
SUPT7L/RBKS
t(2;2)(p23;p23)
  Astrocytoma, grade III-IV/Glioblastoma Brain
SLC4A1AP/GPN1
t(2;2)(p23;p23)
  Adenocarcinoma Breast
ATAD2B/ITSN2
t(2;2)(p23;p23)
  Adenocarcinoma Breast
CLIP4/FAM179A
t(2;2)(p23;p23)
  Adenocarcinoma Breast
DTNB/RBKS
t(2;2)(p23;p23)
  Adenocarcinoma Breast
RAB10/NCOA1
t(2;2)(p23;p23)
  Adenocarcinoma Breast
MRPL33/ZNF512
t(2;2)(p23;p23)
  Adenocarcinoma Breast
PPP1CB/BRE
t(2;2)(p23;p23)
  Adenocarcinoma Breast
ASXL2/KIF3C
t(2;2)(p23;p23)
  Transitional cell carcinoma Bladder
PLB1/BRE
t(2;2)(p23;p23)
  Transitional cell carcinoma Bladder
HADHA/DNAJC27
t(2;2)(p23;p23)

Zheng et al 2016, Cancer Cell
  Adenocarcinoma Adrenal
PPP1CB/BRE
t(2;2)(p23;p23)
  Adenocarcinoma Adrenal
PPP1CB/PLB1
t(2;2)(p23;p23)